These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1224 related articles for article (PubMed ID: 25512156)
1. Screening for cancer in low- and middle-income countries. Sankaranarayanan R Ann Glob Health; 2014; 80(5):412-7. PubMed ID: 25512156 [TBL] [Abstract][Full Text] [Related]
2. Optimizing high risk HPV-based primary screening for cervical cancer in low- and middle-income countries: opportunities and challenges. Pimple SA; Mishra GA Minerva Ginecol; 2019 Oct; 71(5):365-371. PubMed ID: 31698891 [TBL] [Abstract][Full Text] [Related]
3. Cancer screening and early diagnosis in low and middle income countries : Current situation and future perspectives. Mandal R; Basu P Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Dec; 61(12):1505-1512. PubMed ID: 30353287 [TBL] [Abstract][Full Text] [Related]
4. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Brisson M; Kim JJ; Canfell K; Drolet M; Gingras G; Burger EA; Martin D; Simms KT; Bénard É; Boily MC; Sy S; Regan C; Keane A; Caruana M; Nguyen DTN; Smith MA; Laprise JF; Jit M; Alary M; Bray F; Fidarova E; Elsheikh F; Bloem PJN; Broutet N; Hutubessy R Lancet; 2020 Feb; 395(10224):575-590. PubMed ID: 32007141 [TBL] [Abstract][Full Text] [Related]
5. Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential. Sahasrabuddhe VV; Parham GP; Mwanahamuntu MH; Vermund SH Cancer Prev Res (Phila); 2012 Jan; 5(1):11-7. PubMed ID: 22158053 [TBL] [Abstract][Full Text] [Related]
6. Innovative approaches to cervical cancer screening in low- and middle-income countries. Toliman PJ; Kaldor JM; Tabrizi SN; Vallely AJ Climacteric; 2018 Jun; 21(3):235-238. PubMed ID: 29488817 [TBL] [Abstract][Full Text] [Related]
7. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555 [TBL] [Abstract][Full Text] [Related]
8. The next steps in cervical screening. Sankaranarayanan R; Qiao YL; Keita N Womens Health (Lond); 2015 Mar; 11(2):201-12. PubMed ID: 25776294 [TBL] [Abstract][Full Text] [Related]
9. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates. Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886 [TBL] [Abstract][Full Text] [Related]
10. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa. Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747 [TBL] [Abstract][Full Text] [Related]
11. Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi. Cubie HA; Campbell C Womens Health (Lond); 2020; 16():1745506520914804. PubMed ID: 32364058 [TBL] [Abstract][Full Text] [Related]
12. Implementing recommendations for the early detection of breast and cervical cancer among low-income women. Lawson HW; Henson R; Bobo JK; Kaeser MK MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731 [TBL] [Abstract][Full Text] [Related]
13. Factors Influencing the Cost-Effectiveness Outcomes of HPV Vaccination and Screening Interventions in Low-to-Middle-Income Countries (LMICs): A Systematic Review. Okeah BO; Ridyard CH Appl Health Econ Health Policy; 2020 Oct; 18(5):641-654. PubMed ID: 32468410 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review. Mezei AK; Armstrong HL; Pedersen HN; Campos NG; Mitchell SM; Sekikubo M; Byamugisha JK; Kim JJ; Bryan S; Ogilvie GS Int J Cancer; 2017 Aug; 141(3):437-446. PubMed ID: 28297074 [TBL] [Abstract][Full Text] [Related]
15. [Screening for cervical and breast cancer]. Wilm J; Schüler-Toprak S; Ortmann O Pathologe; 2016 Sep; 37(5):477-89. PubMed ID: 27577734 [TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia. Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297 [TBL] [Abstract][Full Text] [Related]
17. History, development and future of cancer screening in Australia. Olver IN; Roder D Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765858 [TBL] [Abstract][Full Text] [Related]
18. [Cervical cancer screening: past--present--future]. Breitenecker G Pathologe; 2009 Dec; 30 Suppl 2():128-35. PubMed ID: 19756616 [TBL] [Abstract][Full Text] [Related]
19. Provision of screening services for cervical and breast cancer - A scientific study commissioned by the European Board & College of Obstetrics and Gynaecology (EBCOG). Vieira-Coimbra M; Nogueira-Martins N; Zadykowicz R; Rodrigues Gaspar H; Calleja-Agius J; Pakiz M; Mukhopadhyay S; Mahmood T Eur J Obstet Gynecol Reprod Biol; 2023 Oct; 289():208-216. PubMed ID: 37679212 [TBL] [Abstract][Full Text] [Related]
20. Mammography screening: A major issue in medicine. Autier P; Boniol M Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]